Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pan

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Circulation. Cardiovascular Quality and Outcomes|October 4, 2022
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19Alexi Vasbinder, Chelsea Meloche, Tariq U Azam, et al.
Aging Cell|September 7, 2025
The Human Cardiac "Age-OME": Age-Specific Changes in Myocardial Molecular ExpressionCassandra Malecki, Giovanni Guglielmi, Benjamin Hunter, et al.
Journal of the American Heart Association|December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
Journal of the American Society of Nephrology : JASN|September 23, 2020
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKITariq U Azam, Husam R Shadid, Pennelope Blakely, et al.
BMJ (Clinical Research Ed.)|October 1, 2020
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort studySalim S Hayek, Samantha K Brenner, Tariq U Azam, et al.
JACC. Cardiooncology|January 11, 2024
Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk FactorsAlexi Vasbinder, Christopher W Hoeger, Tonimarie Catalan, et al.
Diabetes Care|January 19, 2022
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, et al.
Journal of the American Heart Association|August 4, 2022
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19Shengyuan Luo, Alexi Vasbinder, Jeanne M Du-Fay-de-Lavallaz, et al.
Journal of the American Heart Association|December 29, 2023
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk ScoreAlexi Vasbinder, Tonimarie Catalan, Elizabeth Anderson, et al.
Journal of Medical Virology|January 18, 2024
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Quality and Outcomes|October 4, 2022
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19Alexi Vasbinder, Chelsea Meloche, Tariq U Azam, et al.
Aging Cell|September 7, 2025
The Human Cardiac "Age-OME": Age-Specific Changes in Myocardial Molecular ExpressionCassandra Malecki, Giovanni Guglielmi, Benjamin Hunter, et al.
Journal of the American Heart Association|December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
Journal of the American Society of Nephrology : JASN|September 23, 2020
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKITariq U Azam, Husam R Shadid, Pennelope Blakely, et al.
BMJ (Clinical Research Ed.)|October 1, 2020
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort studySalim S Hayek, Samantha K Brenner, Tariq U Azam, et al.
JACC. Cardiooncology|January 11, 2024
Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk FactorsAlexi Vasbinder, Christopher W Hoeger, Tonimarie Catalan, et al.
Diabetes Care|January 19, 2022
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, et al.
Journal of the American Heart Association|August 4, 2022
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19Shengyuan Luo, Alexi Vasbinder, Jeanne M Du-Fay-de-Lavallaz, et al.
Journal of the American Heart Association|December 29, 2023
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk ScoreAlexi Vasbinder, Tonimarie Catalan, Elizabeth Anderson, et al.
Journal of Medical Virology|January 18, 2024
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.
Pageof 7